We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Mikart, a pharmaceutical contract development and manufacturing organization (CDMO), has acquired a state-of-the-art Korsch XM12 to meet their pharmaceutical client demands for complex formulation development and production of oral solid dose products.